ASX Announcement 15 September 2026 Syntara Limited (ASX: SNT), a clinical-stage drug development company, is pleased to advise that its next Annual General Meeting (“AGM”) will be held at 9:00 am (AEDT) on Thursday, 19 November 2026. Pursuant to Listing Rule 3.13.1, the Company advises...
Notification of 2026 AGM Date
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Syntara
- Appendix 4E and Annual Report
- Appendix 4G and Corporate Governance Statement
- Investor Update Webinar Presentation
- Encouraging SNT-4728 Phase 2 iRBD results
- Results of Share Purchase Plan
Later from Syntara
- Application for quotation of securities - SNT
- Syntara receives A$4.7m R&D Tax Incentive
- Syntara expands SNT-9465 skin scarring study
- Notification regarding unquoted securities - SNT
- Further significant results from SNT-4728 iRBD Phase 2 trial
Follow Syntara into a list and get an email when it puts out news.
Follow Syntara